Skip to content
Link copied to clipboard
Link copied to clipboard

FDA adds warning about rare reaction to J&J COVID-19 vaccine

The Centers for Disease Control and Prevention said in a statement it has received reports of 100 people who got the shot developing Guillain-Barré syndrome.

U.S. health officials say Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of a potentially dangerous neurological reaction.
U.S. health officials say Johnson & Johnson’s COVID-19 vaccine may pose a “small possible risk” of a potentially dangerous neurological reaction.Read moreMatt Rourke / AP
    by Matthew Perrone and Mike Stobbe, The Associated Press
    Published